Register
Medicines reference
Product

Futaron

Fusidic Acid · World Medicine

1 form: eye drops. In force in Georgia: 1 of 1 (human register).

Forms and doses1 of 1 in force in Georgia

Form Dose Frequency Georgia
1%, Eye drops No label dose in the reference yet - Georgia Yes, human
In force until 31 Mar 2027
Human (Ministry of Health, RAMA)
№ რ-034828
Verified on: 19 Oct 2026
Details: pack, label wording, sources, registration

Futaron 1%, Eye drops

fusidic acid 10 mg/g, eye drops suspension 5 g, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Proposed off-label ophthalmic antibacterial use in dogs with the Georgian-authorised human Futaron presentation
Not rateable
No numerical score assigned
vetman assessment

Futaron

1%, fusidic acid 10 mg/g, eye drops suspension 5 g, human medicine
Assessed clinical scopeDog · Proposed off-label ophthalmic antibacterial use in dogs with the Georgian-authorised human Futaron presentation · Into the eye
Care settingDo not derive or prescribe a dog/cat regimen from this catalogue record until the exact Georgian leaflet or a dated physical pack resolves the presentation and supplies product-specific directions.
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-034828 · Verified on 19 Oct 2026 Off-label use
Not rateable

A numerical canine score cannot responsibly be assigned. Georgian MIS records Futaron as a 5 g bottle under რ-034828, while official foreign sources document both a 5 g bottle and a 5 ml bottle. No source maps either foreign presentation, leaflet, container, excipients, dosing or after-opening life to the Georgian authorisation. The authorised veterinary Isathal label and fusidic-acid literature describe a clinically plausible class context, but they cannot establish this exact local human product.

The Georgian Futaron record is preserved exactly as a 5 g bottle. Keep the assessment unscored and the calculator blocked until an exact Georgian leaflet or dated pack resolves which presentation is authorised and supplies a dog/cat evidence bridge.

Important safety and use flags

  • Identity boundary: Georgian MIS records Futaron as a 5 g bottle (რ-034828); official foreign sources show both 5 g and 5 ml bottles. Do not replace the Georgian unit or select a foreign leaflet without direct mapping evidence.
  • No dog or cat dose is established for this exact Georgian presentation. The calculator must remain blocked; do not scale a human regimen, copy Isathal dosing or derive drops from concentration.
  • Container, dropper or tube design, viscosity, excipients, preservative, preparation, storage and after-opening life are not established for the exact Georgian authorisation. Do not transfer these facts from a foreign presentation.
  • Examine the eye before any antimicrobial decision. Pain, blepharospasm, corneal opacity or defect, trauma, foreign body, anterior uveitis, glaucoma, or a melting/progressive ulcer requires immediate fluorescein testing and an appropriate ophthalmic plan.
  • Non-transferable class context only: authorised veterinary fusidic acid has a narrow staphylococcal scope and is not suitable for suspected Pseudomonas, fungal or viral disease. That comparator does not validate either Georgian human product.
  • Primary bacterial conjunctivitis is uncommon in dogs. Investigate dry eye, allergy, eyelid or lash disease, foreign material and corneal disease rather than assuming a bacterial indication.
  • This is a Georgian-authorised human product, not the authorised veterinary comparator. Isathal authorisation, target-animal tolerance, pregnancy statements and benefit-risk conclusions do not transfer.
  • Exact-product ocular irritation, hypersensitivity, reproductive safety, immature-animal safety and repeated-course tolerance are not established for dogs or cats. Stop and reassess any worsening or suspected reaction.
  • Use cytology and culture or susceptibility testing where bacterial infection is severe, recurrent, ulcerative, previously treated or non-responsive. Class resistance data cannot identify susceptibility for an individual patient.
  • Do not start or continue empirical treatment from this record. Obtain the exact Georgian leaflet or inspect and document a dated physical pack, then reassess diagnosis, presentation, dose, handling and course before use.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Proposed off-label ophthalmic antibacterial use in cats with the Georgian-authorised human Futaron presentation
Not rateable
No numerical score assigned
vetman assessment

Futaron

1%, fusidic acid 10 mg/g, eye drops suspension 5 g, human medicine
Assessed clinical scopeCat · Proposed off-label ophthalmic antibacterial use in cats with the Georgian-authorised human Futaron presentation · Into the eye
Care settingDo not derive or prescribe a dog/cat regimen from this catalogue record until the exact Georgian leaflet or a dated physical pack resolves the presentation and supplies product-specific directions.
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-034828 · Verified on 19 Oct 2026 Off-label use
Not rateable

A numerical feline score cannot responsibly be assigned. Georgian MIS records Futaron as a 5 g bottle under რ-034828, while official foreign sources document both a 5 g bottle and a 5 ml bottle. No source maps either foreign presentation, leaflet, container, excipients, dosing or after-opening life to the Georgian authorisation. The authorised veterinary Isathal label and fusidic-acid literature describe a clinically plausible class context, but they cannot establish this exact local human product.

The Georgian Futaron record is preserved exactly as a 5 g bottle. Keep the assessment unscored and the calculator blocked until an exact Georgian leaflet or dated pack resolves which presentation is authorised and supplies a dog/cat evidence bridge.

Important safety and use flags

  • Identity boundary: Georgian MIS records Futaron as a 5 g bottle (რ-034828); official foreign sources show both 5 g and 5 ml bottles. Do not replace the Georgian unit or select a foreign leaflet without direct mapping evidence.
  • No dog or cat dose is established for this exact Georgian presentation. The calculator must remain blocked; do not scale a human regimen, copy Isathal dosing or derive drops from concentration.
  • Container, dropper or tube design, viscosity, excipients, preservative, preparation, storage and after-opening life are not established for the exact Georgian authorisation. Do not transfer these facts from a foreign presentation.
  • Examine the eye before any antimicrobial decision. Pain, blepharospasm, corneal opacity or defect, trauma, foreign body, anterior uveitis, glaucoma, or a melting/progressive ulcer requires immediate fluorescein testing and an appropriate ophthalmic plan.
  • Non-transferable class context only: authorised veterinary fusidic acid has a narrow staphylococcal scope and is not suitable for suspected Pseudomonas, fungal or viral disease. That comparator does not validate either Georgian human product.
  • In cats, investigate FHV-1, Chlamydia felis, Mycoplasma, trauma and eyelid or tear-film disease. Fusidic-acid class evidence does not support monotherapy for chlamydiosis or another primary cause.
  • This is a Georgian-authorised human product, not the authorised veterinary comparator. Isathal authorisation, target-animal tolerance, pregnancy statements and benefit-risk conclusions do not transfer.
  • Exact-product ocular irritation, hypersensitivity, reproductive safety, immature-animal safety and repeated-course tolerance are not established for dogs or cats. Stop and reassess any worsening or suspected reaction.
  • Use cytology and culture or susceptibility testing where bacterial infection is severe, recurrent, ulcerative, previously treated or non-responsive. Class resistance data cannot identify susceptibility for an individual patient.
  • Do not start or continue empirical treatment from this record. Obtain the exact Georgian leaflet or inspect and document a dated physical pack, then reassess diagnosis, presentation, dose, handling and course before use.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Fusidic Acid10 mg/g
Formulation Type
Eye drops
Administration route
Into the eye
Manufacturer
World Medicine · Türkiye
Registration
Georgia Yes, human
In force until 31 Mar 2027
Human (Ministry of Health, RAMA)
№ რ-034828
Verified on: 19 Oct 2026
Controlled in Georgia
Unknown
Information not fully verified No dog or cat dose is established for this exact Georgian presentation. General fusidic-acid and Isathal dose rows are deliberately not shown as this product's dose until an exact Georgian leaflet or dated physical pack supplies a direct evidence bridge.

Fusidic Acid: No dose supported by a publicly verifiable source yet

Known Contraindications

  • Critical
    Do not use in conjunctivitis associated with Pseudomonas spp.
    Source: EMA Sources: Irish SPC · EU UPD
  • Critical
    Do not use if hypersensitive to fusidic acid or excipients.
    Source: EMA Sources: Irish SPC · EU UPD

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.